GlassScriptPhysician profile
Ashley L Conner
NPI 1386607430
$8,692.42
in general payments reported to CMS, 2019-2025
53 companies · $1,676 in 2025
The $1,676 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $827 · 2021: $1,242 · 2022: $1,286 · 2023: $1,402 · 2024: $1,680 · 2025: $1,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,657 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,657.41 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,274.27 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $1,132.75 | 2019-2025 | Ubrelvy, Qulipta, Vraylar |
| Pfizer INC. | $1,025.41 | 2019-2025 | |
| Novo Nordisk INC | $670.50 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $573.71 | 2020-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Amgen INC. | $374.04 | 2019-2025 | Otezla, Repatha, Otezla |
| Astellas Pharma US INC | $338.48 | 2020-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $306.41 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $259.17 | 2019-2024 | Jardiance |
| Teva Pharmaceuticals USA, INC. | $223.88 | 2019-2024 | Ajovy, Austedo Xr |
| Merck Sharp & Dohme LLC | $204.47 | 2020-2025 | Capvaxive, Gardasil 9, Rotateq |
| Takeda Pharmaceuticals U.S.A., INC. | $193.59 | 2019-2023 | Trintellix |
| Allergan, INC. | $164.33 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $144.84 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $141.29 | 2019-2023 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $128.76 | 2023-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Dexcom, INC. | $125.41 | 2021-2025 | Dexcom G6 Transmitter |
| Eisai INC. | $102.97 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $102.23 | 2022-2024 | Eliquis, Camzyos |
| Kowa Pharmaceuticals America, INC. | $83.79 | 2020-2024 | Zoryve, Livalo |
| Biohaven Pharmaceutical Holding Company LTD. | $73.79 | 2022 | |
| Organon LLC | $65.87 | 2024-2025 | Nuvaring, Nexplanon |
| Philips North America LLC | $65.56 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $59.74 | 2021 | |
| Sanofi Pasteur INC. | $59.71 | 2019-2022 | |
| Cranial Technologies, INC | $59.55 | 2022-2025 | Doc Band |
| Janssen Pharmaceuticals, INC | $58.99 | 2019-2022 | |
| Axsome Therapeutics, INC. | $56.76 | 2023-2025 | Auvelity |
| Seqirus USA INC | $54.90 | 2023-2025 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $50.44 | 2025 | Caplyta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.68 | 2021-2023 | Xifaxan |
| Esperion Therapeutics, INC. | $39.96 | 2021-2023 | Nexletol |
| Upsher-Smith Laboratories LLC | $33.43 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $33.07 | 2024 | Gemtesa |
| Supernus Pharmaceuticals, INC. | $31.99 | 2021 | Xyosted |
| Sanofi-Aventis U.S. LLC | $31.20 | 2024 | |
| Inari Medical, INC. | $27.94 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Phadia US INC. | $23.58 | 2021 | |
| Aimmune Therapeutics, INC. | $22.08 | 2025 | Zenpep |
| Halozyme INC | $20.75 | 2023 | |
| Jazz Pharmaceuticals INC. | $19.69 | 2021 | |
| Corcept Therapeutics | $19.54 | 2025 | Korlym |
| Shire North American Group INC | $17.69 | 2019 | |
| Lundbeck LLC | $17.45 | 2023 | Rexulti |
| Arbor Pharmaceuticals, INC. | $16.61 | 2021 | |
| Baxter Healthcare | $15.36 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Currax Pharmaceuticals LLC | $15.01 | 2023 | Contrave |
| Phathom Pharmaceuticals, INC. | $14.92 | 2024 | Voquezna |
| Bardy Diagnostics, INC. | $14.84 | 2021 | |
| Antares Pharma, INC. | $14.58 | 2023 | Xyosted, Tlando, Nocdurna |
| Gilead Sciences, INC. | $13.37 | 2019 | |
| Therapeuticsmd, INC. | $12.17 | 2021 | |
| Vivaquant INC, Dba Rhythm Express | $11.90 | 2024 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Conner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.